Core Scientific, Inc.CORZNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -33.12% | -55.64% | -44.28% | -14.95% | -15.97% |
| Gross Profit Growth | -87.88% | -89.42% | -87.05% | +0.00% | +338.46% |
| EBITDA Growth | +0.00% | -107.92% | -101.65% | +0.00% | +0.00% |
| Operating Income Growth | -1111.26% | -177.13% | -499.51% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +175.61% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +58.24% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +66.67% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -20.50% | +36.47% | +78.14% | +8.92% | +4.40% |
| Weighted Average Shares Diluted Growth | -20.50% | +28.59% | +10.60% | +8.92% | +3.97% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -36.39% | -283.09% | +2723.92% | +2206.69% | +1008.79% |
| Free Cash Flow Growth | -248.67% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -85.68% | -8.04% | +5260.20% | -100.00% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +124.50% | +99.68% | +159.77% | +149.06% | +46.84% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | +38.61% | +82.11% | +87.22% | +86.53% | -11.62% |
| R&D Expense Growth | +167.38% | -100.00% | -100.00% | -100.00% | -100.00% |
| SG&A Expenses Growth | +37.17% | +137.03% | +81.44% | +84.57% | -9.39% |